This month we will hear from Kristine Leavitt, CEO, of CovInnovations an emerging company offering novel solutions for diagnosing and treating COVID-19. Then we will hear from Paulo Martins, Founder & CEO of Vitruvian Shield, a digital health company offering a platform for epilepsy remote patient monitoring, diagnosis and research. Finally, we will hear from John Clark, Chairman & CEO of Global Cancer Technology. They have an innovative approach for targeted drug delivery that may change the game for caner patients.
As a member, you are cordially invited to participate in Keiretsu Forum’s Life Science Committee Meetings. Keiretsu believes that through investing in double, triple, and quadruple bottom line companies we can stretch the value of our investment dollars and create a large impact in the world. Through your involvement, planning and participation of this event we are expanding our limits to come together and review startup companies as whole.
This meeting will commence remotely via conference call. The Life Science Committee will meet on the third Tuesday of each month to review life science startup companies and discuss exciting ideas for future social events. Please mark your calendar for this new and improved event!
Wed May 18, 2022
3:30 p.m. – 5:30 p.m.
3:30-3:35 Join call and wait for other LSC members to join
3:35-3:45 CovInnovations presentation
4:00-4:10 Vitruvian Shield presentation
4:30-4:40 Global Cancer Technology presentation
4:55-5:30 Closed door LSC discussion
Please email Lenin Fernandes at firstname.lastname@example.org for the Zoom meeting password.